EUVIMEDEUVIMED entdecken
Crossref

Novel antipsychotic shows efficacy in Phase 2 schizophrenia trial

The Brown University Psychopharmacology Update · 2026-08 · 37 (8) · 6-7

DOI: 10.1002/pu.31476 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Brown University Psychopharmacology Update, online erschienen am 28.06.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Novel antipsychotic shows efficacy in Phase 2 schizophrenia trial. The Brown University Psychopharmacology Update, 37(8), 6-7. https://doi.org/10.1002/pu.31476

Vancouver

Novel antipsychotic shows efficacy in Phase 2 schizophrenia trial. The Brown University Psychopharmacology Update. 2026;37(8):6-7. doi:10.1002/pu.31476

BibTeX
@article{euvimed2026,
  title = {Novel antipsychotic shows efficacy in Phase 2 schizophrenia trial},
  journal = {The Brown University Psychopharmacology Update},
  year = {2026},
  volume = {37},
  number = {8},
  pages = {6--7},
  doi = {10.1002/pu.31476}
}
Kostenlos starten →